Bromazine: Difference between revisions
Jump to navigation
Jump to search
m (Protected "Bromazine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
No edit summary |
||
Line 1: | Line 1: | ||
{{Drugbox | {{Drugbox | ||
| IUPAC_name | | Verifiedfields = changed | ||
| image | | verifiedrevid = 459983265 | ||
| IUPAC_name = 2-[(4-bromophenyl)-phenylmethoxy]-''N'',''N''-dimethylethanamine | |||
| image = Bromazine.svg | |||
| | |||
| | <!--Clinical data--> | ||
| | | tradename = | ||
| MedlinePlus = a682065 | |||
| routes_of_administration = Oral | |||
| bioavailability | <!--Pharmacokinetic data--> | ||
| protein_bound | | bioavailability = High | ||
| metabolism | | protein_bound = 96% | ||
| metabolism = Mostly [[liver|hepatic]] ([[cytochrome P450|CYP]]-mediated), also [[kidney|renal]] | |||
| elimination_half-life = 1 to 4 hours | | elimination_half-life = 1 to 4 hours | ||
<!--Identifiers--> | |||
| | | CASNo_Ref = {{cascite|correct|CAS}} | ||
| | | CAS_number_Ref = {{cascite|correct|??}} | ||
| | | CAS_number = 1808-12-4 | ||
| | | CAS_supplemental = {{CAS|1808-12-4}} | ||
| | | ATC_prefix = R06 | ||
| ATC_suffix = AA01 | |||
| | | PubChem = 2444 | ||
| | | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | ||
| DrugBank = DB01237 | |||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | |||
| ChemSpiderID = 2350 | |||
| UNII_Ref = {{fdacite|correct|FDA}} | |||
| UNII = 202J683U97 | |||
| ChEBI_Ref = {{ebicite|correct|EBI}} | |||
| ChEBI = 59177 | |||
| ChEMBL_Ref = {{ebicite|changed|EBI}} | |||
| ChEMBL = 1201245 | |||
<!--Chemical data--> | |||
| C=17 | H=20 | Br=1 | N=1 | O=1 | |||
| molecular_weight = 334.251 g/mol | |||
| smiles = Brc1ccc(cc1)C(OCCN(C)C)c2ccccc2 | |||
| InChI = 1/C17H20BrNO/c1-19(2)12-13-20-17(14-6-4-3-5-7-14)15-8-10-16(18)11-9-15/h3-11,17H,12-13H2,1-2H3 | |||
| InChIKey = NUNIWXHYABYXKF-UHFFFAOYAG | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C17H20BrNO/c1-19(2)12-13-20-17(14-6-4-3-5-7-14)15-8-10-16(18)11-9-15/h3-11,17H,12-13H2,1-2H3 | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = NUNIWXHYABYXKF-UHFFFAOYSA-N | |||
}} | }} | ||
{{ | '''Bromazine''' (trade names '''Ambrodyl''', '''Ambrodil''' and others), also known as '''bromodiphenhydramine''', is an [[antihistamine]] and [[anticholinergic]].<ref>{{cite pmid|14377226}}</ref> It is a halogenated form of [[diphenhydramine]] and in many respects is somewhat stronger than the parent compound. The other three halogenated diphenhydramine derivatives are used in research and [[chlorodiphenhydramine]] is also marketed with [[iododiphenhydramine]] being a much less common pharmaceutical. | ||
== References == | |||
{{Reflist}} | |||
{{Antihistamines}} | {{Antihistamines}} | ||
{{Cholinergics}} | |||
{{Histaminergics}} | |||
[[Category:H1 receptor antagonists]] | [[Category:H1 receptor antagonists]] | ||
{{ | [[Category:Organobromides]] | ||
[[Category:Ethers]] | |||
[[Category:Amines]] | |||
{{respiratory-system-drug-stub}} |
Revision as of 17:46, 6 April 2015
Clinical data | |
---|---|
MedlinePlus | a682065 |
Routes of administration | Oral |
ATC code | |
Pharmacokinetic data | |
Bioavailability | High |
Protein binding | 96% |
Metabolism | Mostly hepatic (CYP-mediated), also renal |
Elimination half-life | 1 to 4 hours |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C17H20BrNO |
Molar mass | 334.251 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Bromazine (trade names Ambrodyl, Ambrodil and others), also known as bromodiphenhydramine, is an antihistamine and anticholinergic.[1] It is a halogenated form of diphenhydramine and in many respects is somewhat stronger than the parent compound. The other three halogenated diphenhydramine derivatives are used in research and chlorodiphenhydramine is also marketed with iododiphenhydramine being a much less common pharmaceutical.
References
- ↑ PMID 14377226 (PMID 14377226)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
Categories:
- Pages with script errors
- Pages with incomplete PMID references
- Articles with changed EBI identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Articles without KEGG source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- H1 receptor antagonists
- Organobromides
- Ethers
- Amines